secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950103-25-005798
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRL enters cooperation with Elliott, adds 4 directors, launches strategic review
--------------------------------------------------------------------------------

- Four new directors (Steven Barg, Abe Ceesay, Mark Enyedy, Paul Graves) to join board after May 20 annual meeting.
- Four incumbent directors (Bertolini, Kochevar, Massaro, Wallman) will not stand for re-election at 2025 meeting.
- Board will conduct comprehensive strategic review via new Strategic Planning and Capital Allocation Committee.
- Cooperation agreement with Elliott includes standstill, voting commitments, and mutual non-disparagement.
- Board size capped at 11 members during cooperation period; Barg and Enyedy appointed as Elliott designees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000095010325005798/0000950103-25-005798-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000095010325005798/dp228602_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-25-005798

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer